Invesco Nasdaq Biotechnology ETF (IBBQ) is a Invesco ETF with a 0.19% expense ratio, 256 holdings and $115MM in net assets. Largest sector: Healthcare (100%).
Fee
0.19%
expense ratio
Net assets
$115MM
Launched
Jun 11, 2021
Holdings
256
as of Oct 10, 2026
Top 10 weight
46.5%
largest ten holdings
Largest sector
Healthcare
100.0%
Yield
30-day SEC 0.31%
as of Oct 22, 2026
Benchmark
NASDAQ Biotechnology Index
IBBQ's holdings are as of Oct 10, 2026.
Healthcare
100.0%
1
GILD
GILEAD SCIENCES
8.41%
2
AMGN
AMGEN
7.87%
3
VRTX
VERTEX PHARMACEUTICALS
7.63%
4
MRNA
MODERNA
5.99%
5
REGN
REGENERON PHARMACEUTICALS
5.03%
6
ILMN
ILLUMINA
2.80%
7
RVMD
Revolution Medicines
2.71%
8
BIIB
BIOGEN
2.22%
9
ALNY
Alnylam Pharmaceuticals
2.08%
10
ROIV
Roivant Sciences Ltd.
1.71%
11
RPRX
ROYALTY PHARMA
1.69%
12
UTHR
United Therapeutics
1.57%
13
INCY
INCYTE
1.52%
14
GH
Guardant Health
1.50%
15
ARGX
ARGENX
1.49%
16
INSM
Insmed
1.46%
17
VTRS
VIATRIS
1.35%
18
MEDP
Medpace Holdings
1.13%
19
EXEL
Exelixis
0.99%
20
NBIX
Neurocrine Biosciences
0.96%
21
JAZZ
Jazz Pharmaceuticals
0.95%
22
SMMT
Summit Therapeutics
0.94%
23
ASND
Ascendis Pharma A/S
0.94%
24
BBIO
Bridgebio Pharma
0.87%
25
ONC
BEONE MEDICINES LTD-ADR
0.84%
1–25 of 256
Funds listed by how much of their largest holdings they share with IBBQ — not a ranking.
Data from Invesco; prices and returns from market data. Page updated October 29, 2026. Holdings and figures change over time. For information only — not investment advice.